tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Stock Forecast & Price Target

Compare
3 Followers
See the Price Targets and Ratings of:

1541 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
ImmuneOnco
Biopharmaceuticals (Shanghai) Inc Class H
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1541 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1541 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1541 Financial Forecast

1541 Earnings Forecast

The previous quarter’s earnings for 1541 were -HK$0.41.
The previous quarter’s earnings for 1541 were -HK$0.41.

1541 Sales Forecast

The previous quarter’s earnings for 1541 were HK$40.85M.
The previous quarter’s earnings for 1541 were HK$40.85M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guoyuan Securities (HK) Analyst forecast on HK:1541
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
HK$21.89
Buy
255.93%
Upside
Reiterated
06/03/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guoyuan Securities (HK) Analyst forecast on HK:1541
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
HK$21.89
Buy
255.93%
Upside
Reiterated
06/03/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1541 Analyst Recommendation Trends

Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 1541 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1541 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

1541 Stock Forecast FAQ

What is HK:1541’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1541’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1541, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H a Buy, Sell or Hold?
      Currently, no data Available
      What is ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H’s share price target?
      Currently, no data Available
      What do analysts say about ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H?
      To buy shares of HK:1541, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.